Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF After Induction Chemotherapy in Adults With Newly Diagnosed Acute Myeloid Leukemia
ChiCTR2600116861Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2026
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of filgrastim in acute myeloid leukemia (AML) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Absolute neutrophil count and Infection events. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
filgrastim
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on ChiCTR2600116861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116861.